TF access | TA access | TAo access | ||||
Xw/Xwo | p-value | Xw/Xwo | p-value | Xw/Xwo | p-value | |
Valve size | 0.038 | 0.005 | 0.001 | |||
20–23 mm | 37.5 / 31.4 | 29.5 / 30.7 | 26.6 / 30.8 | |||
26 mm | 23.2 / 39.3 | 49.2 / 40.9 | 49.5 / 44.9 | |||
29 mm | 39.3 / 29.3 | 21.3 / 28.5 | 23.9 / 24.4 | |||
Quantity contrast agent used (mL) | 131 / 120 | 0.240 | 85 / 80 | 0.681 | 94 / 80 | 0.008 |
Effective orifice area post-surgery | 1.40 / 1.65 | 0.203 | 2.10 / 2.00 | 0.222 | 1.80 / 1.82 | 0.809 |
Indexed effective orifice area | 0.71 / 0.87 | 0.175 | 1.17 / 1.04 | 0.137 | 1.04 / 1.00 | 0.857 |
AV mean PG post-surgery | 12 / 11 | 0.138 | 4 / 5 | 0.641 | 9 / 10 | 0.863 |
Paravalvular regurgitation | 0.001 | < 0.001 | < 0.001 | |||
None/trace | 85.7 / 86.0 | 78.7 / 84.7 | 76.6 / 80.8 | |||
Mild | 14.3 / 13.2 | 21.3 / 14.6 | 19.4 / 19.2 | |||
Moderate | 0 / 0.7 | 0 / 0.7 | 3.6 / 0 | |||
Severe | 0 / 0 | 0 / 0 | 0.5 / 0 | |||
TF access | TA access | TAo access | ||||
Xw/Xwo | OR (95% CI) | Xw/Xwo | OR (95% CI) | Xw/Xwo | OR (95%CI) | |
Post-delivery balloon dilation (%) | 30.4 / 15.7 | 0.43 (0.21–0.89) | 14.8 / 9.5 | 1.65 (0.65–4.07) | 22.5 / 25.6 | 0.84 (0.47–1.56) |
Access complications (%) | 0 / 5 | n.a. | 0 / 0.7 | n.a. | 1.4 / 0 | n.a. |
Hemodynamic instability (%) | 3.6 / 0.7 | 0.19 (0.01–2.07) | 6.6 / 4.4 | 0.65 (0.18–2.63) | n.c. | n.a. |
Catecholamine use (%) | 1.8 / 0.7 | 0.4 (0.02–10.12) | 32.8 / 17.5 | 0.44 (0.22–0.87) | n.c. | n.a. |
Device success (%) | 92.9 / 98.6 | 5.31 (1.01–39.12) | 100 / 100 | n.a. | 98.6 / 98.7 | 0.95 (0.05–7.53) |
Second valve needed (%) | 0 / 0.7 | n.a. | 0 / 0 | n.a. | 1.8 / 2.6 | 0.7 (0.13–5.1) |
Conversion to surgery (%) | 0 / 2.9 | n.a. | 0 / 1.5 | n.a. | 1.7 / 0 | n.a. |
Device malfunction (%) | 0 / 0 | n.a. | 0 / 0.7 | n.a. | 0.9 / 0 | n.a. |
Atrioventricular block (%) | 3.6 / 2.1 | 0.59 (0.1–4.58) | 1.6 / 1.5 | 0.89 (0.08–19.34) | 5 / 0 | n.a. |
Aortic root rupture (%) | 0 / 0 | n.a. | 0 / 0 | n.a. | 0.5 / 0.0 | n.a. |
Correct positioning of a single prosthetic valve into the proper anatomical location (%) | 100 / 100 | n.a. | 100 / 100 | n.a. | 98.6 / 98.7 | 1.05(0.13–21.5) |
Intended performance of the prosthetic valve (%) | 92.9 / 98.6 | 5.31 (1.01–39.1) | 100 / 100 | n.a. | 99.1 / 98.7 | 0.7 (0.07–15.2) |